Mast Therapeutics formerly ADVENTRX Pharmaceuticals, is a biopharmaceutical company with its headquarters in San Diego, Calif. The company is engaged in developing ANX-188, its lead product candidate, through leveraging the MAST (Molecular Adhesion and Sealant Technology) platform, which is derived from more than two decades of clinical, nonclinical and manufacturing experience with purified and non-purified poloxamers. For more information, visit the company’s Web site: http://www.masttherapeutics.com
Let us hear your thoughts below: